| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |